MyBlueDotsOncology & CancerLung cancer trial reveals 40% drop in deaths using biomarker testing MyBlueDots5 days ago01 mins New research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of lung cancer led to a major reduction in deaths. Go to Source Author: Post navigation Previous: Data-driven study reveals falling use of antiseizure drug in pregnancyNext: AI analysis reveals four long COVID patient subgroups and needs
Powered by machine learning, a new blood test can enable early detection of multiple cancers MyBlueDots2 days ago 0